Silverman Louis E.'s most recent trade in Insight Molecular Diagnostics Inc. was a trade of 7,700 Common Stock, no par value done at an average price of $5.7 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc | Louis E. Silverman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.69 per share. | 01 Jul 2026 | 7,700 | 55,807 (0%) | 0% | 5.7 | 43,813 | Common Stock, no par value |
| Staar Surgical Co. | Louis E. Silverman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 10,683 | 11,158 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 10,683 | 0 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 6,182 | 6,182 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnostics Inc | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 26,943 | 63,507 (0%) | 0% | 0 | Common Stock, no par value | |
| Veradigm Inc | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 42,507 | 99,131 (0%) | 0% | 0 | Common Stock | |
| Insight Molecular Diagnostics Inc | Silverman Louis E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 35,000 | 36,564 (0%) | 0% | 0 | Common Stock, no par value | |
| Staar Surgical Co. | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,683 | 10,683 | - | - | Restricted Stock Units | |
| Veradigm Inc | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 4.30 per share. | 02 Jun 2025 | 46,512 | 56,624 (0%) | 0% | 4.3 | 200,002 | Common Stock |
| Staar Surgical Co. | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,440 | 2,440 | - | - | Common Stock Options | |
| Veradigm Inc | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 10,112 | 10,112 (0%) | 0% | 0 | Common Stock | |
| Insight Molecular Diagnostics Inc | Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 30,000 | 30,000 | - | - | Option to Purchase Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 10,000 | 2,924 (0%) | 0% | 145.6 | 1,455,600 | Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 10,000 | 0 | - | - | Common Stock Options | ||
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 10,000 | 0 | - | - | Common Stock Options | ||
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 10,000 | 12,924 (0%) | 0% | 8.4 | 83,500 | Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 10,000 | 2,924 (0%) | 0% | 145.6 | 1,455,700 | Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 10,000 | 12,924 (0%) | 0% | 9.3 | 93,100 | Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 9,921 | 0 | - | - | Common Stock Options | ||
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 9,921 | 2,924 (0%) | 0% | 145.5 | 1,443,902 | Common Stock | |
| Staar Surgical Co. | Louis E. Silverman | Director | 10 Aug 2021 | 9,921 | 12,845 (0%) | 0% | 9.6 | 95,242 | Common Stock |